Cell Therapeutics' Special Meeting of Shareholders adjourned to June 4, 2010

Download PDF Copy

Editorial Checklist

Reviewed

Cell Therapeutics, Inc.May 15 2010

Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) (the "Company") today announced that the Company has adjourned today's Special Meeting of Shareholders (the "Special Meeting") to 10:00 am Pacific Daylight Time, Friday, June 4, 2010.

The Company's proxy materials previously filed with the Securities and Exchange Commission (the "SEC") on February 23, 2010 and the proposals being submitted to a vote of the shareholders at the Special Meeting as described in such proxy materials remain unchanged. The Company encourages those shareholders that held shares as of February 19, 2010, the record date of the Special Meeting, to vote their shares on the proposals.

Source:

Cell Therapeutics, Inc.

Posted in:

Comments (0)

Download PDF Copy

Suggested Reading

Rare lung cell found to protect against COVID-19 death

Rare lung cell found to protect against COVID-19 death

Scientists unlock secrets of how cells navigate the body

Scientists unlock secrets of how cells navigate the body

Bruker to launch Beacon Discovery™ at AACR 2025, expanding access to live single-cell functional analysis

Bruker to launch Beacon Discovery™ at AACR 2025, expanding access to live single-cell functional analysis

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

AI tools improve detection of key immune structures in melanoma

AI tools improve detection of key immune structures in melanoma

New approach targets cell surface protein to treat leukemia and solid tumors

New approach targets cell surface protein to treat leukemia and solid tumors

Influenza virus hijacks human gene regulator to evade immune system

Influenza virus hijacks human gene regulator to evade immune system

iPS cell transplants show early promise for treating Parkinson's disease safely

iPS cell transplants show early promise for treating Parkinson's disease safely

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

New CAR T cell therapy shows promise for treating advanced thyroid cancer